Overexpression of glypican-1 implicates poor prognosis and their chemoresistance in oesophageal squamous cell carcinoma. - Wikidata - awgldk - TriplyDB

Overexpression of glypican-1 implicates poor prognosis and their chemoresistance in oesophageal squamous cell carcinoma.

Overexpression of glypican-1 implicates poor prognosis and their chemoresistance in oesophageal squamous cell carcinoma.

http://www.wikidata.org/entity/Q37061381

about

Glypican-1 targeted antibody-based therapy induces preclinical antitumor activity against esophageal squamous cell carcinoma Elevated glypican-1 expression is associated with an unfavorable prognosis in pancreatic ductal adenocarcinoma.Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment.Anti-glypican-1 antibody-drug conjugate exhibits potent preclinical antitumor activity against glypican-1 positive uterine cervical cancer.Therapeutically targeting glypican-2 via single-domain antibody-based chimeric antigen receptors and immunotoxins in neuroblastoma.Glypican-1 immunohistochemistry is a novel marker to differentiate epithelioid mesothelioma from lung adenocarcinoma.Detection of glypican-1 (GPC-1) expression in urine cell sediments in prostate cancer.

P2860

Q33648638-C66A0067-E938-498B-B0A7-9A967B2BFADF Q33775264-3B82CB4F-9E4A-40A1-ABA6-7A6DD9A23F69 Q39378285-39602DA0-1EB1-4958-B837-4E1BA4205F8B Q47750583-5E221430-F2C0-4C29-A307-47860BE2A0B5 Q48355318-D982C3EB-B902-45E3-AFA8-5EB31B19F29A Q50071611-A676F7F2-0D8E-4F60-9ABE-08DC7D32DD80 Q54986662-F57DC21F-05F2-4B09-880C-BAD59C58D7EC

P2860

Overexpression of glypican-1 implicates poor prognosis and their chemoresistance in oesophageal squamous cell carcinoma.

http://www.wikidata.org/entity/Q37061381

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 16 June 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Overexpression of glypican-1 i ...... ageal squamous cell carcinoma.

@en

Overexpression of glypican-1 i ...... ageal squamous cell carcinoma.

@nl

type

label

Overexpression of glypican-1 i ...... ageal squamous cell carcinoma.

@en

Overexpression of glypican-1 i ...... ageal squamous cell carcinoma.

@nl

prefLabel

Overexpression of glypican-1 i ...... ageal squamous cell carcinoma.

@en

Overexpression of glypican-1 i ...... ageal squamous cell carcinoma.

@nl

P1433

Q37061381-52B20BFE-FD66-4339-BF93-9511AFFCE39E

P1476

Q37061381-7A613D60-A63B-4ED5-8F8C-52E23CAE4F6A

P2093

Q37061381-071AC4CD-8A8A-4CFB-AE9F-911B7FC26571

Q37061381-11C06F40-F1DD-4D2F-A9A1-E5BDEF9AA292

Q37061381-13BA4C58-2A4C-46AA-8061-330267084701

Q37061381-183E355A-007E-4E13-BEC1-B5E7EA544079

Q37061381-23FD9AEF-AEAE-43F7-936C-D6065CC99832

Q37061381-380B8608-8771-4597-893A-DB3CD75A33BF

Q37061381-5A937397-7D13-409A-853A-51025211F3EB

Q37061381-5F0C24FF-885B-41A2-99A7-BECEAFCC1665

Q37061381-83FCA6B4-86DD-468D-8249-800C7126B123

Q37061381-844DAC04-2270-419D-A411-C29E57C0D9A2

P2860

Q37061381-0B980701-035C-43ED-8B10-D52582E93B9D

Q37061381-1061035A-5556-406E-B854-3B81935BC4F6

Q37061381-186CDF5E-FF5F-402E-AFCD-2CCE7F758988

Q37061381-27D14968-9FC9-4133-9C04-F296BB2229F3

Q37061381-3BDB67EF-338A-4D4F-8B40-144B4CD10ED1

Q37061381-436D25E6-8E36-487D-9694-BCC0DA39B7F5

Q37061381-5620F8DF-2759-4074-B3D9-8F4DBC1E850F

Q37061381-5B619B12-48C9-4150-8AEF-DCFB9D4AF549

Q37061381-65BA8CB5-2FE9-4BF1-B456-73A99AB5F900

Q37061381-6726B7F2-7C5E-4D67-9999-6364CDCC2274

P2888

Q37061381-D9C1D742-A256-4AB6-A115-EB727719882D

P304

Q37061381-347EE515-1523-4531-BEAD-B9831DDCABE7

P31

Q37061381-4F505874-2F73-4DD3-8A43-4981169A0D64

P356

Q37061381-BDD77F22-0C52-43F6-A9E8-B010B4C7190E

P407

Q37061381-BA0E445C-53CB-491B-8D64-278A5F6F1ACC

P433

Q37061381-8137CF8A-8477-4376-B33E-6B7013A1B090

P478

Q37061381-65B21FEF-C2F4-4990-A700-7DE674655D1C

P50

Q37061381-0C687512-FEA6-440A-AFCC-D5A8DE9F7B00

Q37061381-1326AB41-2B3E-42F1-85E0-54C9B544B75E

Q37061381-5DB9F6C6-B293-47E8-98A8-B6037C0B8436

Q37061381-6E924F86-3C3C-4CC7-BB56-5C47C134CE0D

Q37061381-779873B7-69FF-49C1-8D39-119D25FA7810

Q37061381-DE25E043-470C-4E73-B9AB-27552EF8CD10

P577

Q37061381-5877C17B-93E3-4308-AC64-394489187035

P698

Q37061381-FD582593-8238-441F-96B8-00C153B4F3E9

P921

Q37061381-1CF3B89C-8BBF-4890-BFBF-DC1266EB7288

P932

Q37061381-6E602557-80DF-4D13-8AB6-5CA27D7C70D3

P356

P1433

British Journal of Cancer

P1476

Overexpression of glypican-1 i ...... hageal squamous cell carcinoma

@en

P2093

Eiichi Morii

http://www.w3.org/2001/XMLSchema#string

Emi Harada

http://www.w3.org/2001/XMLSchema#string

Hiroshi Miyata

http://www.w3.org/2001/XMLSchema#string

Kiyokazu Nakajima

http://www.w3.org/2001/XMLSchema#string

Makoto Yamasaki

http://www.w3.org/2001/XMLSchema#string

Rie Nakatsuka

http://www.w3.org/2001/XMLSchema#string

Satoshi Nojima

http://www.w3.org/2001/XMLSchema#string

Shuji Takiguchi

http://www.w3.org/2001/XMLSchema#string

Takahiko Nishigaki

http://www.w3.org/2001/XMLSchema#string

Tomoharu Ohkawara

http://www.w3.org/2001/XMLSchema#string

P2860

Direct detection of HSulf-1 and HSulf-2 activities on extracellular heparan sulfate and their inhibition by PI-88

The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer

Glypican-1 is frequently overexpressed in human gliomas and enhances FGF-2 signaling in glioma cells

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

Reevaluation of Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma: A Meta-Analysis of Randomized Controlled Trials Over the Past 20 Years

Glypican-1 is a VEGF165 binding proteoglycan that acts as an extracellular chaperone for VEGF165

Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells

Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents

Oesophageal carcinoma.

Controls for immunohistochemistry: the Histochemical Society's standards of practice for validation of immunohistochemical assays.

P2888

P304

66-75

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.2016.183

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

115

http://www.w3.org/2001/XMLSchema#string

P50

Minoru Fujimoto

P577

2016-06-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27310703

http://www.w3.org/2001/XMLSchema#string

P921

P932

4931380

http://www.w3.org/2001/XMLSchema#string